Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_assertion type Assertion NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_head.
- NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_assertion description "[Methylation associated inactivation of RASSF1, a putative tumor suppressor identified at 3p21.3, has been frequently observed in several human malignancies, including lung and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_provenance.
- NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_assertion evidence source_evidence_literature NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_provenance.
- NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_assertion SIO_000772 11585730 NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_provenance.
- NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_assertion wasDerivedFrom befree-2016 NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_provenance.
- NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_assertion wasGeneratedBy ECO_0000203 NP331873.RAXf2Uf9vo342myTJb95WZHrlU-mM1naCFyR5PfRK_4NY130_provenance.